Management of Low Serum IgA in Children

Definition and Epidemiology

Selective IgA deficiency (SIGAD) is defined as serum IgA concentrations below the age‑adjusted lower limit of normal while IgG and IgM remain within normal ranges. 3
Approximately 2.5 % of the general population will have at least one immunoglobulin measurement below the laboratory reference range solely due to statistical variation. 1

A single low IgA result should not be used to diagnose immunodeficiency; repeat quantitative measurements of IgA, IgG, and IgM at least one month apart to confirm persistence. 1
Concurrent assessment of total serum protein and albumin is recommended to exclude secondary causes such as protein‑losing enteropathy, nephrotic syndrome, or lymphatic disorders. 1
A systematic review of current and recent medications is essential because several drugs (e.g., antiepileptics, rituximab, sulfasalazine, gold salts, penicillamine, hydroxychloroquine, NSAIDs) can induce reversible hypogammaglobulinemia. 1

Immunoglobulin replacement therapy should not be initiated based only on low IgA; functional antibody responses must be evaluated. 1
Vaccine‑induced antibody responses to protein antigens (e.g., tetanus, diphtheria) are the primary method to differentiate clinically significant immunodeficiency from benign variation. 1
In children > 6 years with recurrent infections, polysaccharide antibody responses should be measured 2–4 weeks after pneumococcal polysaccharide vaccination (Pneumovax‑23).
- A protective response is defined as ≥ 1.3 µg/mL for > 70 % of tested serotypes.
- Severe impairment is indicated when < 2 serotypes reach protective levels. 1

Most individuals with SIGAD are asymptomatic and do not require specific therapy. 3
For children with low IgA who experience recurrent sinopulmonary infections, first‑line management includes aggressive antimicrobial treatment and prophylactic antibiotics targeting common encapsulated and atypical respiratory pathogens. 1
Immunoglobulin replacement therapy is reserved for patients who demonstrate both documented impaired vaccine responses and recurrent infections that significantly affect quality of life despite optimal antimicrobial therapy. 1

Periodic monitoring of immunoglobulin levels is advised to detect evolution toward a definitive immunodeficiency or spontaneous resolution. 1

Primary immunodeficiency should not be diagnosed in children < 4 years solely on the basis of low immunoglobulin levels, as transient hypogammaglobulinemia of infancy is common and usually resolves spontaneously. 4
IgA deficiency alone does not warrant IgG replacement therapy unless there is concurrent IgG deficiency with impaired vaccine responses and clinically significant infections. 1
Patients with IgA deficiency may develop anti‑IgA antibodies, increasing the risk of anaphylaxis with blood product transfusion; therefore, washed red blood cells or IgA‑deficient blood products should be used when transfusion is required. 3
Drug‑induced immunoglobulin abnormalities are frequently overlooked but are often reversible after discontinuation of the offending agent. 1